1 Min Read
June 16 (Reuters) - IPSEN SA:
* IPSEN ANNOUNCES FDA APPROVAL OF DYSPORT (ABOBOTULINUMTOXINA) FOR THE TREATMENT OF LOWER LIMB SPASTICITY IN ADULTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.